PUMA BIOTECHNOLOGY, INC. — Director's Dealing 2019

Sep 25, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PUMA BIOTECHNOLOGY, INC. (PBYI)
CIK: 0001401667
Period of Report: 2019-09-10

Reporting Person: HUNT DOUGLAS M (See Remarks)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-09-10	Common Stock	A	4500	$0.00	Acquired	14400	Direct
2019-09-12	Common Stock	S	1711	$11.42	Disposed	12689	Direct

Footnotes

F1: Shares issued pursuant to performance based vesting of restricted stock units.

F2: The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units.